Biolojic’s BD9 is a multibody that was computationally designed as a multi specific antibody targeting IL-13 / TSLP to treat inflammatory diseases. Agreement builds on Teva's Pivot to Growth strategy ...
Oct 22 (Reuters) - Chip firm Arm is cancelling an architectural license agreement that allows Qualcomm (QCOM.O), opens new tab to use its intellectual property to design chips, a person familiar with ...
Chip firm Arm is cancelling an architectural license agreement that allows Qualcomm to use its intellectual property to design chips, a person familiar with the matter said, amid an ongoing legal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback